Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TENM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDPF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAP30BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHX8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDCCAG8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXLNG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP3K2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPUSD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TYW5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NRDC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCTD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MAP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CANT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP3K3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRRC2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSX2IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on